Home » Topics » Conferences

Conferences
RSS

Lilly presents orally active growth hormone secretagogues at ACS meeting

Aug. 24, 1999

ACS research news: Neurocrine Biosciences presents newest CRF antagonist

Aug. 24, 1999

Steroidal "ante drugs" from Affymax have potent activity in the lungs, short half-life in plasma

Aug. 24, 1999

ACS highlights: DuPont investigates dual MMP/TNF-alpha production inhibitors

Aug. 24, 1999

Two new RAR antagonists emerge from retinoid research program at Bristol-Myers Squibb

Aug. 24, 1999

Org-23366: an atypical antipsychotic potentially superior to clozapine

Aug. 23, 1999

ACS news: Wyeth-Ayerst investigates agents for urinary incontinence

Aug. 23, 1999

Phase II results validate Emisphere's technology for oral delivery of heparin

Aug. 23, 1999

Preclinical profile of rPSGL-Ig indicates clinical testing is warranted

Aug. 23, 1999

Dual TP antagonist/TxA2 synthase inhibitor presented by Servier

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...